FDG PET and FES PET Predict PFS on Endocrine Therapy-Letter

Clin Cancer Res. 2018 Jan 1;24(1):248. doi: 10.1158/1078-0432.CCR-17-2380.

Authors

Lemonitsa H Mammatas¹, Erik J van Helden¹, Henk M W Verheul¹, Catharina W Menke-van der Houven van Oordt²

Affiliations

¹ VUmc Cancer Center Amsterdam, VU University Medical Center, Department of Medical Oncology, Amsterdam, the Netherlands.
² VUmc Cancer Center Amsterdam, VU University Medical Center, Department of Medical Oncology, Amsterdam, the Netherlands. [email protected].

PMID: 29298807
DOI: 10.1158/1078-0432.CCR-17-2380

No abstract available

Publication types

Letter
Comment

MeSH terms

Breast Neoplasms*
Fluorodeoxyglucose F18*
Humans
Positron-Emission Tomography
Progression-Free Survival
Receptors, Estrogen

Substances

Receptors, Estrogen
Fluorodeoxyglucose F18